際際滷shows by User: jtkoutsik / http://www.slideshare.net/images/logo.gif 際際滷shows by User: jtkoutsik / Tue, 08 Dec 2015 19:32:25 GMT 際際滷Share feed for 際際滷shows by User: jtkoutsik Management of low-risk thyroid cancer /slideshow/management-of-lowrisk-thyroid-cancer/55947517 koutsikosohrid-151208193225-lva1-app6892
It is unclear whether the administration of radioiodine provides any benefit in low-risk cases after a complete surgical resection, and radioiodine is not recommended in patients with disease that is categorized as consisting of a tumor less than 1 cm in diameter and clinical stage N0. Therefore, radioiodine should be used with great care to minimize harm, administer the minimal amount of radioactivity, and involve the best tolerated methods. ]]>
It is unclear whether the administration of radioiodine provides any benefit in low-risk cases after a complete surgical resection, and radioiodine is not recommended in patients with disease that is categorized as consisting of a tumor less than 1 cm in diameter and clinical stage N0. Therefore, radioiodine should be used with great care to minimize harm, administer the minimal amount of radioactivity, and involve the best tolerated methods. ]]> Tue, 08 Dec 2015 19:32:25 GMT /slideshow/management-of-lowrisk-thyroid-cancer/55947517 jtkoutsik@slideshare.net(jtkoutsik) Management of low-risk thyroid cancer jtkoutsik It is unclear whether the administration of radioiodine provides any benefit in low-risk cases after a complete surgical resection, and radioiodine is not recommended in patients with disease that is categorized as consisting of a tumor less than 1 cm in diameter and clinical stage N0. Therefore, radioiodine should be used with great care to minimize harm, administer the minimal amount of radioactivity, and involve the best tolerated methods. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/koutsikosohrid-151208193225-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> It is unclear whether the administration of radioiodine provides any benefit in low-risk cases after a complete surgical resection, and radioiodine is not recommended in patients with disease that is categorized as consisting of a tumor less than 1 cm in diameter and clinical stage N0. Therefore, radioiodine should be used with great care to minimize harm, administer the minimal amount of radioactivity, and involve the best tolerated methods.
Management of low-risk thyroid cancer from John Koutsikos
]]> 958 9 https://cdn.slidesharecdn.com/ss_thumbnails/koutsikosohrid-151208193225-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Radioiodine dosage and modality koutsikos /slideshow/radioiodine-dosage-and-modality-koutsikos/55947388 radioiodinedosageandmodalitykoutsikos-151208192813-lva1-app6892
There are many guidelines and recommendations suggesting ablation/therapy in Differentiated Thyroid Carcinoma. This presentation will be focused on the details of these recommendations and guidelines. Furthermore, it will be discussed the use of recombinant human thyrotropin (rhTSH) prior to radioactive iodine remnant ablation for patients with differentiated thyroid cancer.]]>
There are many guidelines and recommendations suggesting ablation/therapy in Differentiated Thyroid Carcinoma. This presentation will be focused on the details of these recommendations and guidelines. Furthermore, it will be discussed the use of recombinant human thyrotropin (rhTSH) prior to radioactive iodine remnant ablation for patients with differentiated thyroid cancer.]]> Tue, 08 Dec 2015 19:28:13 GMT /slideshow/radioiodine-dosage-and-modality-koutsikos/55947388 jtkoutsik@slideshare.net(jtkoutsik) Radioiodine dosage and modality koutsikos jtkoutsik There are many guidelines and recommendations suggesting ablation/therapy in Differentiated Thyroid Carcinoma. This presentation will be focused on the details of these recommendations and guidelines. Furthermore, it will be discussed the use of recombinant human thyrotropin (rhTSH) prior to radioactive iodine remnant ablation for patients with differentiated thyroid cancer. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/radioiodinedosageandmodalitykoutsikos-151208192813-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> There are many guidelines and recommendations suggesting ablation/therapy in Differentiated Thyroid Carcinoma. This presentation will be focused on the details of these recommendations and guidelines. Furthermore, it will be discussed the use of recombinant human thyrotropin (rhTSH) prior to radioactive iodine remnant ablation for patients with differentiated thyroid cancer.
Radioiodine dosage and modality koutsikos from John Koutsikos
]]> 855 5 https://cdn.slidesharecdn.com/ss_thumbnails/radioiodinedosageandmodalitykoutsikos-151208192813-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Nuclear Medicine in Spondyloarthropathies /slideshow/nuclear-medicine-in-spondyloarthropathies/34245103 nuclearmedicineinspa-140503164615-phpapp01
Is there any role for Nuclear Medicine in the investigation of Spondyloarthropathies in the era of MRI?]]>
Is there any role for Nuclear Medicine in the investigation of Spondyloarthropathies in the era of MRI?]]> Sat, 03 May 2014 16:46:15 GMT /slideshow/nuclear-medicine-in-spondyloarthropathies/34245103 jtkoutsik@slideshare.net(jtkoutsik) Nuclear Medicine in Spondyloarthropathies jtkoutsik Is there any role for Nuclear Medicine in the investigation of Spondyloarthropathies in the era of MRI? <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nuclearmedicineinspa-140503164615-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Is there any role for Nuclear Medicine in the investigation of Spondyloarthropathies in the era of MRI?
Nuclear Medicine in Spondyloarthropathies from John Koutsikos
]]> 605 4 https://cdn.slidesharecdn.com/ss_thumbnails/nuclearmedicineinspa-140503164615-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 H 慮劉侶 凌 SPECT-CT 侶僚 竜僚隆凌虜旅僚凌了凌粒溜留 /slideshow/h-spectct-10553187/10553187 spectct-111211160539-phpapp02
裡竜亮旅僚略旅凌 & 05-11-2011]]>
裡竜亮旅僚略旅凌 & 05-11-2011]]> Sun, 11 Dec 2011 16:05:35 GMT /slideshow/h-spectct-10553187/10553187 jtkoutsik@slideshare.net(jtkoutsik) H 慮劉侶 凌 SPECT-CT 侶僚 竜僚隆凌虜旅僚凌了凌粒溜留 jtkoutsik 裡竜亮旅僚略旅凌 & 05-11-2011 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/spectct-111211160539-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> 裡竜亮旅僚略旅凌 &amp; 05-11-2011
H 慮劉侶 凌 SPECT-CT 侶僚 竜僚隆凌虜旅僚凌了凌粒溜留 from John Koutsikos
]]> 399 2 https://cdn.slidesharecdn.com/ss_thumbnails/spectct-111211160539-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Patient preparation for radioiodine treatment /slideshow/patient-preparation-for-radioiodine-treatment/10536126 presentation-111209135154-phpapp02
Guidelines for patients that are receiving I-131 for thyroid diseases (benign and DTC)]]>
Guidelines for patients that are receiving I-131 for thyroid diseases (benign and DTC)]]> Fri, 09 Dec 2011 13:51:52 GMT /slideshow/patient-preparation-for-radioiodine-treatment/10536126 jtkoutsik@slideshare.net(jtkoutsik) Patient preparation for radioiodine treatment jtkoutsik Guidelines for patients that are receiving I-131 for thyroid diseases (benign and DTC) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/presentation-111209135154-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Guidelines for patients that are receiving I-131 for thyroid diseases (benign and DTC)
Patient preparation for radioiodine treatment from John Koutsikos
]]> 1128 3 https://cdn.slidesharecdn.com/ss_thumbnails/presentation-111209135154-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 RIT in benign thyroid disease /slideshow/rit-in-benign-thyroid-disease/10536103 ritinbenignthyroiddisease-111209134916-phpapp02
Radioiodine treatment in benign thyroid diseases]]>
Radioiodine treatment in benign thyroid diseases]]> Fri, 09 Dec 2011 13:49:14 GMT /slideshow/rit-in-benign-thyroid-disease/10536103 jtkoutsik@slideshare.net(jtkoutsik) RIT in benign thyroid disease jtkoutsik Radioiodine treatment in benign thyroid diseases <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ritinbenignthyroiddisease-111209134916-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Radioiodine treatment in benign thyroid diseases
RIT in benign thyroid disease from John Koutsikos
]]> 578 2 https://cdn.slidesharecdn.com/ss_thumbnails/ritinbenignthyroiddisease-111209134916-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 E旅慮亮侶劉 虜留旅 留僚竜旅慮亮侶竜 隆略竜旅 留亮略虜僚 旅 竜両竜略竜旅 侶 .. /jtkoutsik/e-10474229 random-111205173516-phpapp01
Drug interactions in Nuclear Medicine studies.]]>
Drug interactions in Nuclear Medicine studies.]]> Mon, 05 Dec 2011 17:35:13 GMT /jtkoutsik/e-10474229 jtkoutsik@slideshare.net(jtkoutsik) E旅慮亮侶劉 虜留旅 留僚竜旅慮亮侶竜 隆略竜旅 留亮略虜僚 旅 竜両竜略竜旅 侶 .. jtkoutsik Drug interactions in Nuclear Medicine studies. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/random-111205173516-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Drug interactions in Nuclear Medicine studies.
E旅慮亮侶劉 虜留旅 留僚竜旅慮亮侶竜 隆略竜旅 留亮略虜僚 旅 竜両竜略竜旅 侶 .. from John Koutsikos
]]> 1815 2 https://cdn.slidesharecdn.com/ss_thumbnails/random-111205173516-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-jtkoutsik-48x48.jpg?cb=1601203071 https://cdn.slidesharecdn.com/ss_thumbnails/koutsikosohrid-151208193225-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/management-of-lowrisk-thyroid-cancer/55947517 Management of low-risk... https://cdn.slidesharecdn.com/ss_thumbnails/radioiodinedosageandmodalitykoutsikos-151208192813-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/radioiodine-dosage-and-modality-koutsikos/55947388 Radioiodine dosage and... https://cdn.slidesharecdn.com/ss_thumbnails/nuclearmedicineinspa-140503164615-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/nuclear-medicine-in-spondyloarthropathies/34245103 Nuclear Medicine in Sp...